Click main image to view in full screen. Unlock all 14 preview images:
Biotech & Pharma Startup Financial Model – Excel XLSX
Excel (XLSX) + Excel (XLSX)
BENEFITS OF THIS DOWNLOADABLE EXCEL DOCUMENT
- Provides a structured 10-year biotech and pharma startup forecasting model with editable assumptions and formula-driven outputs.
- Helps evaluate valuation, funding requirements, cash runway, pipeline potential, and investor return metrics.
- Includes both Lite and Advanced Pro versions, allowing users to choose between simplified planning and deeper institutional-style analysis.
BIOTECH EXCEL DESCRIPTION
π Biotech & Pharma Startup Financial Model Bundle β Lite + Advanced Pro
This Excel financial model bundle is designed for biotech, pharmaceutical, life sciences, and R&D-driven startup businesses requiring structured financial forecasting, feasibility analysis, valuation, funding planning, and investor presentation outputs.
The bundle includes two editable Excel models:
β
Lite / Basic Version β a simplified 10-year biotech/pharma startup model covering inputs, pipeline assumptions, forecast, financial statements, valuation, dashboard, and checks.
β
Advanced Pro Version β a more detailed model including scenario control, assumptions, pipeline, clinical development timeline, launch forecast, R&D budget, headcount, financial statements, rNPV, DCF valuation, sensitivity analysis, cap table, dashboard, and integrity checks.
The model helps users analyze revenue potential, development cost, R&D spend, launch timing, cash runway, funding requirements, enterprise value, equity value, and probability-adjusted valuation.
It is suitable for founders, CFOs, startup advisors, consultants, financial analysts, biotech incubators, investment professionals, and life sciences teams preparing fundraising or feasibility analysis.
The workbook is fully editable and built with a clean structure so users can replace the sample assumptions with their own business case.
π Use this model for:
β’ Startup fundraising
β’ Biotech valuation
β’ Pharma pipeline planning
β’ Investor presentations
β’ Financial feasibility analysis
β’ Scenario and sensitivity review
β’ Funding requirement planning
β’ Cash runway analysis
This is a practical, investor-focused financial modeling toolkit for biotech and pharma startup planning.
Got a question about the product? Email us at support@flevy.com or ask the author directly by using the "Ask the Author a Question" form. If you cannot view the preview above this document description, go here to view the large preview instead.
Source: Best Practices in Biotech, Integrated Financial Model Excel: Biotech & Pharma Startup Financial Model Excel (XLSX) Spreadsheet, PDMM Financial Models
ABOUT THE AUTHOR
PDMM Financial Models develops professional, decision-ready Excel models for business owners, entrepreneurs, investors, consultants, analysts, and finance teams. Our objective is to transform complex business assumptions into clear, structured analysis that supports better planning and investment decisions.
Our models cover business planning, forecasting, budgeting, feasibility analysis,
... [read more]
Ask the Author a Question
You must be logged in to contact the author.
